{"id":11261,"date":"2018-08-21T10:11:16","date_gmt":"2018-08-21T14:11:16","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11261"},"modified":"2018-08-21T10:13:08","modified_gmt":"2018-08-21T14:13:08","slug":"should-pharma-and-congress-do-more-to-cut-drug-prices","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11261","title":{"rendered":"Should Pharma and Congress do more to cut drug prices?"},"content":{"rendered":"<p><span style=\"color: #000000; font-family: Calibri;\">In a conference call with reporters, Health and Human Services (HHS) Secretary Alex Azar said Congress and drugmakers should be doing more to lower the cost of prescription drugs. Azar gave the example of \u201cThe industry could move further to a fixed price discount system at the point of sale;&#8221; there\u2019s nothing stopping them. To read more of Secretary Azar\u2019s comments, click on attached link. <a href=\"https:\/\/www.medpagetoday.com\/publichealthpolicy\/generalprofessionalissues\/74657\">Click here\u2026<\/a><\/span><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/09\/HHS-seal.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-8242\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/09\/HHS-seal-300x203.jpg\" alt=\"\" width=\"300\" height=\"203\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/09\/HHS-seal-300x203.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/09\/HHS-seal.jpg 339w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>In a conference call with reporters, Health and Human Services (HHS) Secretary Alex Azar said Congress and drugmakers should be<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,20,15],"tags":[],"class_list":["post-11261","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-health-care-redesign","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11261"}],"version-history":[{"count":3,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11261\/revisions"}],"predecessor-version":[{"id":11264,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11261\/revisions\/11264"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}